UK markets close in 6 hours 42 minutes

PDS Biotechnology Corporation (PDSB)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.3500-0.0400 (-1.18%)
At close: 04:00PM EDT
3.2500 -0.10 (-2.99%)
After hours: 07:34PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 122.88M
Enterprise value 90.17M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.70
Enterprise value/revenue N/A
Enterprise value/EBITDA -2.25

Trading information

Stock price history

Beta (5Y monthly) 1.72
52-week change 3-46.66%
S&P500 52-week change 323.10%
52-week high 310.2700
52-week low 32.5900
50-day moving average 34.3440
200-day moving average 34.9888

Share statistics

Avg vol (3-month) 3902.41k
Avg vol (10-day) 3627.47k
Shares outstanding 536.68M
Implied shares outstanding 636.68M
Float 835.28M
% held by insiders 13.67%
% held by institutions 122.89%
Shares short (15 Apr 2024) 47.14M
Short ratio (15 Apr 2024) 46.47
Short % of float (15 Apr 2024) 420.39%
Short % of shares outstanding (15 Apr 2024) 419.48%
Shares short (prior month 15 Mar 2024) 45.51M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Mar 2019
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 318 Mar 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-39.45%
Return on equity (ttm)-122.46%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -42.99M
Net income avi to common (ttm)-42.94M
Diluted EPS (ttm)-1.3900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)56.56M
Total cash per share (mrq)1.54
Total debt (mrq)23.85M
Total debt/equity (mrq)91.28%
Current ratio (mrq)4.33
Book value per share (mrq)0.79

Cash flow statement

Operating cash flow (ttm)-33.64M
Levered free cash flow (ttm)-21.17M